August 13, 2014
ME Graduate Student Matt Adams Awarded Whitaker International Fellowship
PhD graduate student Matt Adams was recently awarded with a prestigious Whitaker International Fellowship to undertake an independent research project at the University of Oxford’s biomedical ultrasonics, biotherapy, and biopharmaceuticals laboratory (BUBBL). The highly competitive Whitaker International Program sends emerging leaders in U.S. biomedical engineering, or a closely related field, overseas to undertake a self-designed project, with the goal of enhancing their careers and assisting their development into a professional leader with an international outlook.
From January until September in 2014, Matt will be visiting Oxford where he will be developing a novel, acousto-optically guided focused ultrasound system for the minimally invasive thermal ablation of tumors. His project will contribute to the BUBBL’s existing research aimed at the identification, optimization, and modeling of key mechanisms that can simultaneously enhance non-invasive therapy and enable real-time monitoring and control of therapeutic processes deep within the body. “Acousto-optic imaging and sensing techniques present a unique approach to monitoring and guiding high-intensity, non-cavitating focused ultrasound treatments, and could provide physicians with a minimally invasive strategy for treating optically accessible organs such as the breast, brain, and prostate,” said Matt. He also added, “I’d like to thank the Whitaker International Program and the researchers at the BUBBL for this unique opportunity.”
Professor Ron Roy, Matt’s advisor, commented, “This is both a great opportunity and a nice distinction for Matt. Entry into the Whitaker International Fellows Program is extremely competitive and it is difficult to overstate the value spending a year abroad with a top group. In addition to working with academic leaders such as Profs. Robin Cleveland and Constantin Coussios, Matt will be able to interface with a top clinical HIFU group at the RMH Institute for Cancer Research as well as with colleagues at the University of Southampton, Imperial College London, and University College London. It should be an exciting, broadening, and productive year.”